ArticleCancers2021

Transformed Lymphoma Is Associated with a Favorable Response to CAR-T-Cell Treatment in DLBCL Patients.

Anna Nydegger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.